Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Supplemental Oxygen Therapy on Neurocognitive Performance in Healthy Highlanders
NCT07651917Phase 4Not yet recruiting
- Sponsor
- University of Zurich
- Start
- Jun 2026
- Primary completion
- Jul 2026
01
Overview
A Phase 4 trial of oxygen in cognitive impairment, sponsored by University of Zurich. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
oxygen
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT07651917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07651917.